$ENVA

Fisher David sold $6.6M of ENVA

Fisher David (Executive Chairman) sold 33,060 shares of Enova International, Inc. (ENVA) at $199.05 ($6.58M total) on 2026-06-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fisher David
Published Jun 22, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 22, 2026, 8:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ENVA
Neutral
medium confidence
Mentioned
$ENVA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ENVANeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and post-transaction holdings by the executive chairman under a pre-arranged 10b5-1 plan.

02

Market read

This is a routine insider-sale filing; it may slightly influence sentiment but is unlikely to drive a major repricing absent additional corroborating news.

03

What to watch

Traders may want to compare this sale’s size versus prior Form 4 activity and check whether multiple insiders are selling on similar schedules.

Relevance 5/10Novelty 5/10Timing: Filed 2026-06-22 after-hours; sale executed 2026-06-17.

Background

The article is an SEC Form 4 insider transaction disclosure for Enova International, Inc. (ENVA).

Company-level read

Ticker impact

$ENVANeutralMedium confidence
Context

Enova executive chairman David Fisher sold 33,060 shares in an open-market transaction at $199.0514 on 2026-06-17 under a 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely muted unless follow-on sales accelerate or size increases materially.

Evidence & confidence

The filing is a Form 4 with a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

No clear sector read-through; this is company-specific insider liquidity disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated or larger-than-usual insider sales can still coincide with management’s view of near-term valuation risk.

Key entities

  • Enova International, Inc.

    Subject of the Form 4 insider transaction; executive chairman David Fisher sold shares under a 10b5-1 plan.

  • David Fisher

    Executive Chairman; reported open-market sale of 33,060 ENVA shares at $199.0514 on 2026-06-17.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ENVAMedAI 8/10

Enova International subsidiary announces $500 million asset-backed notes offering

Enova International's subsidiary plans a $500M asset-backed notes offering, with four classes of notes ranging from 5.61% to 8.28% interest. The notes are backed by small business loans and expected to be rated by Kroll. Enova reported strong Q2 2026 earnings, exceeding estimates, but withdrew a bank acquisition due to regulatory challenges. Citizens lowered its price target to $215, maintaining an Outperform rating.

$ENVAMedAI 8/10

Enova to issue $500.026M Series 2026-1 asset-backed notes backed by OnDeck loans

Enova plans to issue $500.026M in asset-backed notes due 2026, secured by OnDeck small business loans. The notes, divided into four classes, have fixed rates ranging from 5.61% to 8.28%. KBRA is expected to rate the notes AA(sf) to BB(sf). The proceeds will be used to purchase loans from OnDeck and fund a reserve account. The offering is targeted at qualified institutional buyers under Rule 144A and offshore under Regulation S, with a closing date around September 25, 2026, subject to conditions